With regard to cognitive disorders, we have used this platform to explain the differential clinical effect of memantine and apolipoprotein E (APOE) on ADAS-Cog in Alzheimer patients (Roberts et al., 2012b). The gene discussed is APOE; the disease is Cognitive impairment.